GL1X · GenesisL1 explorer

MolNFT v1 · #89075 · protein

Crystal structure of C-met in complex with triazolopyridazine inhibitor 2

4DEG · Hepatocyte growth factor receptor: “Crystal structure of C-met in complex with triazolopyridazine inhibitor 2”. X-ray diffraction, 1 ligand (0JJ), 2 pockets (best druggability 0.62). MolNFT v1 #89075 on GenesisL1: 3D structure…

PDB
4DEG
Type
protein
Length
286 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatocyte growth factor receptor
EC
2.7.10.1
UniProt
P08581
Ligands
0JJ
Pockets
2 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatocyte growth factor receptor (EC 2.7.10.1)protein28642% helix, 15% strandP08581

Ligands and binding sites

  • 0JJ · 7-methoxy-N-{[6-(3-methyl-1,2-thiazol-5-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}-1,5-naphthyridin-4-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11880.620.83270JJ
22580.570.7734empty

Compared structures

  • 4DEG · Crystal structure of c-Met in complex with triazolopyridazine inhibitor 2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.